Rapt Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
RAPT Therapeutics details its 2024 financial performance and outlines key developments in its clinical-stage immunology-based biopharmaceutical programs.
RAPT Therapeutics, a clinical-stage biopharmaceutical company, released its 2023 financial results and provided updates on its clinical development programs, including a recent clinical hold on its zelnecirnon trials.